Modeling Ribavirin‐Induced Anemia in Patients with Chronic Hepatitis C Virus

Modeling Ribavirin‐Induced Anemia in Patients with Chronic Hepatitis C Virus

Ribavirin remains an important component of hepatitis C treatment in certain clinical scenarios, but it causes hemolytic anemia. A quantitative understanding of the ribavirin exposure‐anemia relationship is important in dose individualization/optimization. We developed a model relating ribavirin tri...

Full description

Saved in:

Bibliographic Details
Main Authors:	LS Wu, LC Jimmerson, CE MacBrayne, JJ Kiser, DZ D'Argenio
Format:	Article
Language:	English
Published:	Wiley 2016-02-01
Series:	CPT: Pharmacometrics & Systems Pharmacology
Online Access:	https://doi.org/10.1002/psp4.12058
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of ribavirin efficacy and tolerance in subjects with chronic hepatitis C virus infection
by: Stanimirović Violeta, et al.
Published: (2002-01-01)

Treatment of chronic hepatitis C by cepeginterferon alpha-2b in combination to ribavirin
by: M. V. Mayevskaya, et al.
Published: (2014-08-01)

Sequence variation of the HVR1 region of Hepatitis C virus in response to interferon-α and ribavirin treatment
by: Ahmed Ali Al-Qahtani, et al.
Published: (2011-05-01)

Anti-Hepatitis C Activity of Combination of Ruta angustifolia Extract and Ribavirin
by: Tutik Sri Wahyuni, et al.
Published: (2022-08-01)

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
by: Konstantinos D. Pantazis, et al.
Published: (2008-01-01)

Real-life data on the efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir +ribavirin in the patients with genotype 1 chronic hepatitis C virus infection in Serbia
by: Simonović-Babić Jasmina, et al.
Published: (2019-01-01)

Early virologic response to сеpeginterferon alfa-2b in combination with ribavirin in treatment of patients with chronic hepatitis C
by: O. O. Znoyko, et al.
Published: (2014-09-01)

Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy
by: Ružić Maja, et al.
Published: (2018-01-01)

Treatment of anicteric acute hepatitis C with peginterferon alpha-2a plus ribavirin
by: Delić Dragan, et al.
Published: (2005-01-01)

Efficacy of Sofosbuvir and Ribavirin in Children Presenting with Hepatitis C at Tertiary Care Hospital, Faisalabad
by: Nagina Shahzadi, et al.
Published: (2023-04-01)

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

The efficacy and safety of double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alfa 2b and ribavirin) treatment regimens in chronic hepatitis C patients. The experience of everyday clinical practice
by: N. P. Blokhina, et al.
Published: (2016-07-01)

Review: Remote disease monitoring in rheumatoid arthritis
by: Amy MacBrayne, et al.
Published: (2022-01-01)

Kinetics of Virus Load HCV-RNA in Blood Serum and Peripheral Mononuclear Cells in a Patient with Hepatocirrhosis and Chronic Virus Hepatitis C Termination Treated According to Noninterferon Treatment Scheme (Cycloferon + Ribavirin)
by: V. C. Stelmah, et al.
Published: (2020-05-01)

Responses to peginterferon alfa-2a vs alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
by: Jorge Luis Sandoval-Ramirez, et al.
Published: (2015-03-01)

Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and Boceprevir
by: Csilla Putz-Bankuti, et al.
Published: (2013-01-01)

Response to Pegylated Interferon Plus Ribavirin in Patients with Hepatitis C Virus Genotype 6a Infection from Guangdong and Guangxi Province of China
by: Wangxia Tong, et al.
Published: (2016-01-01)

Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists
by: Peter Wang, et al.
Published: (2003-01-01)

Hepatitis C Eradication and Improvement of Cryoglobulinemia-Associated Rash and Membranoproliferative Glomerulonephritis with Interferon and Ribavirin after Kidney Transplantation
by: Marilyn Zeman, et al.
Published: (2006-01-01)

Does a Rapid Decline in the Hematological and Biochemical Parameters Induced by Interferon and Ribavirin Combination Therapy for the Hepatitis C Virus Predict a Sustained Viral Response?
by: Christian Turbide, et al.
Published: (2008-01-01)

Chronic Kidney Disease and Hepatitis C virus.
by: Clara C. Sánchez-Rodríguez, et al.
Published: (2025-04-01)

A Case of Giant Cell Hepatitis Recurring after Liver Transplantation and Treated with Ribavirin
by: Ziad Hassoun, et al.
Published: (2000-01-01)

Interaction of hepatitis C virus with the immune system in pregnant women with chronic hepatitis C
by: A. P. Tsibulkin, et al.
Published: (2019-05-01)

Inhibition of Tick-Borne Encephalitis Virus Replication with Eprosartan and Ribavirin In Vitro and In Vivo
by: G. N. Leonova, et al.
Published: (2020-12-01)

Ribavirin therapy for Chikungunya arthritis
by: Rajan Ravichandran, et al.
Published: (2008-04-01)

Positive association between chronic hepatitis B virus infection and anemia in pregnancy in Southern China
by: Renliang Huang, et al.
Published: (2025-01-01)

Cycloferon Therapy of Acute and Chronic Virus Hepatitis C
by: V. P. Malyy, et al.
Published: (2020-05-01)

Histopathology of chronic hepatitis C in relation to virus genotype
by: Simonović Jasmina, et al.
Published: (2006-01-01)

THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
by: Sumit Dahal, et al.
Published: (2017-03-01)

Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials
by: Zongguo Yang, et al.
Published: (2013-01-01)

EFFICACY AND SAFETY OF THE COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON ALFA-2A IN PATIENTS WITH CHRONIC HEPATITIS C: THE RESULTS OF TWO MULTICENTER, PROSPECTIVE, OPEN, NON-COMPARATIVE CLINICAL TRIALS
by: K. V. Zhdanov, et al.
Published: (2018-01-01)

Risk Factors for Hepatitis C Virus Infection in Canadian Patients with Chronic Type C Hepatitis
by: GY Minuk, et al.
Published: (1995-01-01)

INVESTIGATION OF THE SIGNIFICANCE OF DETECTION OF THE NUCLEOCAPSID ANTIGEN OF THE HEPATITIS C VIRUS IN CHILDREN WITH CHRONIC HEPATITIS C
by: E. A. Leybman, et al.
Published: (2017-12-01)

An Efficient Chemoenzymatic Process for Preparation of Ribavirin
by: Vladimir Sakharov, et al.
Published: (2015-01-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

The Structure of Hepatitis C Virus Genotypes/Subtypes in Adult Patients with Chronic Hepatitis C in the Moscow Region
by: E. N. Kudryavtseva, et al.
Published: (2016-04-01)

The role of different virus genotypes in progression of chronic hepatitis C
by: Nožić Darko, et al.
Published: (2002-01-01)

High risk of hepatic complications in kidney transplantation with chronic hepatitis C virus infection
by: Shih-Ting Huang, et al.
Published: (2025-08-01)

Hepatitis G virus in Saudi blood donors and chronic hepatitis B and C patients
by: Abdulkarim Alhetheel, et al.
Published: (2014-01-01)

Health Care Professionals’ Knowledge of Stalking Perpetrators, Victims, Behaviors, and Coping Strategies: A Preliminary Study among Italian Hospitals
by: Daniela Acquadro Maran, et al.
Published: (2019-01-01)